International Biotechnology Trust PLC Halozyme Therapeutics, Inc. Transaction History

International Biotechnology Trust PLC

$295 Million
Q3 2023

A detailed history of International Biotechnology Trust PLC transactions in Halozyme Therapeutics, Inc. stock. As of the latest transaction made, International Biotechnology Trust PLC holds 62,200 shares of HALO stock, worth $3.26 Million. This represents 0.81% of its overall portfolio holdings.

Number of Shares

62,200

Previous 95,500 34.87%

Holding current value

$3.26 Million

Previous $3.44 Million 31.01%

% of portfolio

0.81%

Previous 1.07%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$36.46 - $44.03 $1.21 Million - $1.47 Million	-33,300 Reduced 34.87%	62,200 $2.38 Million
Q2 2023 Aug 08, 2023	BUY	$30.28 - $38.74 $1.51 Million - $1.94 Million	50,000 Added 109.89%	95,500 $3.44 Million
Q1 2023 May 18, 2023	BUY	$32.86 - $55.7 $1.5 Million - $2.53 Million	45,500 New	45,500 $1.74 Million
Q3 2021 Nov 12, 2021	SELL	$38.47 - $46.42 $3.18 Million - $3.84 Million	-82,633 Closed	0 $0
Q2 2021 Aug 11, 2021	BUY	$38.84 - $51.31 $1.86 Million - $2.46 Million	48,000 Added 138.6%	82,633 $3.75 Million

Q1 2021 May 17, 2021	SELL	$39.51 - $51.45 $10.8 Million - $14 Million	-273,000 Reduced 88.74%	34,633 $1.44 Million
Q4 2019 May 18, 2020	BUY	$14.93 - $19.53 $3.81 Million - $4.98 Million	255,000 Added 484.49%	307,633 $5.45 Million
Q3 2019 Nov 14, 2019	SELL	$15.2 - $17.69 $6.43 Million - $7.48 Million	-423,000 Reduced 88.93%	52,633 $816,000
Q1 2019 May 14, 2019	BUY	$13.94 - $17.58 $1.07 Million - $1.35 Million	77,000 Added 19.32%	475,633 $7.66 Million
Q4 2018 Feb 14, 2019	SELL	$13.33 - $18.66 $399,900 - $559,800	-30,000 Reduced 7.0%	398,633 $4.58 Million
Q3 2018 Nov 14, 2018	BUY	$16.68 - $18.41 $6.79 Million - $7.49 Million	407,033 Added 1884.41%	428,633 $5.97 Million
Q3 2018 Nov 13, 2018	SELL	$16.68 - $18.41 $6.79 Million - $7.49 Million	-407,033 Reduced 94.96%	21,600 $2.79 Million
Q2 2018 Aug 13, 2018	BUY	$16.87 - $20.3 $1.18 Million - $1.42 Million	70,000 Added 19.52%	428,633 $7.23 Million
Q1 2018 May 15, 2018	BUY	$17.06 - $21.2 $1.3 Million - $1.61 Million	76,000 Added 26.89%	358,633 $7.03 Million
Q3 2017 Mar 02, 2018	BUY	$11.76 - $17.4 $917,280 - $1.36 Million	78,000 Added 38.12%	282,633 $4.91 Million
Q2 2017 Mar 02, 2018	SELL	N/A	-153,367 Reduced 42.84%	204,633 $2.62 Million
Q1 2017 Mar 02, 2018	BUY	N/A	300,000 Added 517.24%	358,000 $4.64 Million
Q4 2016 Mar 02, 2018	BUY	N/A	58,000	58,000 $572,000

Others Institutions Holding HALO

# of Institutions

441

Shares Held

122M

Call Options Held

216K

Put Options Held

140K

View Full List

About HALOZYME THERAPEUTICS, INC.

Ticker HALO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 139,288,992
Market Cap $7.29B
Description
Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...

More about HALO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of International Biotechnology Trust PLC, based on Form 13F filings with the SEC.

News

Stay updated on International Biotechnology Trust PLC with notifications on news.

Account

International Biotechnology Trust PLC Halozyme Therapeutics, Inc. Transaction History